Log In
Print
BCIQ
Print
Print this Print this
 

Human anthrax monoclonal antibody (Thravixa)

  Manage Alerts
Collapse Summary General Information
Company Emergent BioSolutions Inc.
DescriptionHuman anthrax mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationAnthrax
Indication DetailsTreat anthrax infection
Regulatory Designation

EU - Orphan Drug (Treat anthrax infection)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today